Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123418
Published online Jan 21, 2027. doi: 10.3748/wjg.123418
Published online Jan 21, 2027. doi: 10.3748/wjg.123418
Figure 1 Treatment patterns and colectomy rates stratified by ulcerative colitis disease activity at diagnosis.
A: Cumulative medication exposure in patients with mild-to-moderate ulcerative colitis (UC); B: Cumulative medication exposure in patients with moderate-to-severe UC; C: Sequencing of advanced therapies in patients with mild-to-moderate UC; D: Sequencing of advanced therapies in patients with moderate-to-severe UC; E: Cumulative incidence of colectomy according to baseline disease activity. 5-ASA: 5-aminosalicylate.
- Citation: Yang WJ, Yao LY, Cao YS, Xia WH, Cao XH, Xu YN, Miao YJ, Cao Q. Long-term treatment trajectories and surgical outcomes in Chinese patients with ulcerative colitis. World J Gastroenterol 2027; 33(3): 123418
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/123418.htm
- DOI: https://dx.doi.org/10.3748/wjg.123418